miR-154 inhibits prostate cancer cell proliferation by targeting CCND2
Chen Zhu(Hunan University of Science and Technology), Changjun Yin(Sun Yat-sen University), Jie Li(Nanjing Medical University), Pu Li(Shanghai Jiao Tong University), Chao Qin(Jiangsu Province Hospital), Xiaobing Ju(Jiangsu Province Hospital), Xiaoxin Meng(Nanjing Medical University), Pengfei Shao(Jiangsu Province Hospital), Qiang Cao(Kunming University of Science and Technology), Hai Zhou(Yuncheng University), Hongzhou Cai(Jiangsu Province Hospital), Liangjun Tao(Jiangsu Province Hospital), Meiling Bao(Jiangsu Province Hospital)
Urologic Oncology Seminars and Original Investigations
February 19, 2013
Cited by 62
Related Papers
Exosome–transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression
|Molecular Cancer|2018|298
An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction
|Nature Communications|2015|202
Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression
|European Urology|2017|202
Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment
|Cell Research|2015|176
MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF
|Biomedicine & Pharmacotherapy|2014|166